leisure time -WSS

leisure time

author：fashion 2025-08-12 11:29:41 - browse：73

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Wikipedia

focus

WSS

Why Talkspace is targeting Medicare, a tricky market

NEJM study measures Covid brain fog, impact on IQ

Fetal cell organoids grown from amniotic fluid, study finds

Elisabeth Bik tackles the widespread issue of research misconduct

Longer MASH drug regimen improved liver, Akero study finds

Study fuels hope CAR

leisure time

leisure time

focus

Bright Health sells Medicare Advantage business to Molina

Virtual repurposing can help discover new uses for existing drugs

Apple is now the first public company to be valued at $3 trillion

Laying a path for careers in science

Trump demands the U.S. pay no more for drugs than other countries … again

Immune cells and nerve overgrowth may explain recurring UTI pain

Medicare proposal to cover medical devices draws a mixed reaction

Elisabeth Bik tackles the widespread issue of research misconduct

State Dept. review finds Biden bears some blame for Afghanistan failures

Fetal cell organoids grown from amniotic fluid, study finds

entertainment

Color Health wants to make cancer screenings convenient

Medicare Advantage isn’t working — for anyone

'Vaccine

Medicare isn't yet testing food as medicine

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

STAT Madness 2024: Meet the contenders

Wikipedia

focus

focus

focus